These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18503700)
1. Serum pro-hepcidin as an indicator of iron status in dialysis patients. Tsuchihashi D; Abe T; Komaba H; Fujii H; Hamada Y; Nii-Kono T; Tanaka M; Fukagawa M Ther Apher Dial; 2008 Jun; 12(3):226-31. PubMed ID: 18503700 [TBL] [Abstract][Full Text] [Related]
2. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia. Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412 [TBL] [Abstract][Full Text] [Related]
3. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs]. Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526 [TBL] [Abstract][Full Text] [Related]
4. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin. Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521 [TBL] [Abstract][Full Text] [Related]
5. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Malyszko J; Malyszko JS; Mysliwiec M Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706 [TBL] [Abstract][Full Text] [Related]
6. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020 [TBL] [Abstract][Full Text] [Related]
7. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467 [TBL] [Abstract][Full Text] [Related]
8. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study. Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184 [TBL] [Abstract][Full Text] [Related]
9. Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients. Arabul M; Gullulu M; Yilmaz Y; Eren MA; Baran B; Gul CB; Kocamaz G; Dilek K Med Sci Monit; 2009 Nov; 15(11):CR583-7. PubMed ID: 19865058 [TBL] [Abstract][Full Text] [Related]
10. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Sasu BJ; Li H; Rose MJ; Arvedson TL; Doellgast G; Molineux G Blood Cells Mol Dis; 2010 Oct; 45(3):238-45. PubMed ID: 20800515 [TBL] [Abstract][Full Text] [Related]
11. Serum pro-hepcidin levels and relationships with iron parameters in healthy preterm and term newborns. Tiker F; Celik B; Tarcan A; Kilicdag H; Ozbek N; Gurakan B Pediatr Hematol Oncol; 2006 Jun; 23(4):293-7. PubMed ID: 16621770 [TBL] [Abstract][Full Text] [Related]
12. Maternal pro-hepcidin at term correlates with cord blood pro-hepcidin at birth. Ervasti M; Sankilampi U; Luukkonen S; Heinonen S; Punnonen K Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):161-5. PubMed ID: 19740590 [TBL] [Abstract][Full Text] [Related]
13. [Pro-hepcidin, its relation with indicators of iron metabolism and of inflammation in patients hemodialyzed treated or not with recombinant erythropoietin]. Barrios Y; Espinoza M; Barón MA Nutr Hosp; 2010; 25(4):555-60. PubMed ID: 20694291 [TBL] [Abstract][Full Text] [Related]
14. Pro-hepcidin and iron metabolism parameters in multi-time blood donors. Boinska J; Zekanowska E; Kwapisz J Int J Lab Hematol; 2010 Oct; 32(5):483-90. PubMed ID: 19968722 [TBL] [Abstract][Full Text] [Related]
15. Does hepcidin affect erythropoiesis in hemodialysis patients? Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323 [TBL] [Abstract][Full Text] [Related]
16. Hepcidin is not a marker of chronic inflammation in atherosclerosis. Oğuz A; Uzunlulu M; Hekim N Anadolu Kardiyol Derg; 2006 Sep; 6(3):239-42. PubMed ID: 16943108 [TBL] [Abstract][Full Text] [Related]
17. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447 [TBL] [Abstract][Full Text] [Related]
18. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. Kuragano T; Shimonaka Y; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T Am J Nephrol; 2010; 31(6):534-40. PubMed ID: 20484891 [TBL] [Abstract][Full Text] [Related]
19. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540 [TBL] [Abstract][Full Text] [Related]
20. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks. Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]